| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Gorlin Steve serves as a Director at IBRX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 48 buys and 37 sells. Those positions are worth an estimated $763K at current prices.
The biggest single holding is IBRX (~$704K) as Director. The recent filings there lean toward selling, a net 1,401,445 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 18, 2018 | IBRX Immunitybio, Inc. | Director | Sell | 15,971 | $3.97 | $63,412.86 | -3.6% | |
| May 17, 2018 | IBRX Immunitybio, Inc. | Director | Sell | 81,743 | $4.05 | $331,453.34 | -5.5% | |
| Sep 13, 2017 | IBRX Immunitybio, Inc. | Director | Sell | 39,604 | $5.93 | $234,728.95 | -13.9% | |
| Sep 12, 2017 | IBRX Immunitybio, Inc. | Director | Sell | 103,841 | $6.04 | $627,417.30 | -9.6% | |
| Jun 20, 2017 | IBRX Immunitybio, Inc. | Director | Sell | 40,000 | $7.78 | $311,200.00 | -4.8% | |
| Oct 16, 2015 | OTRKQ Ontrak, Inc. | Director | Buy | 300,000 | $0.30 | $90,000.00 | +200.0% | |
| Aug 21, 2015 | IBRX Immunitybio, Inc. | Director | Sell | 450,000 | $23.00 | $10,350,000.00 | -67.0% |